Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography
Open accessAbstract
We provide the first evidence for the capability of a high-resolution positron emission tomographic (PET) imaging system in quantitatively mapping amyloid accumulation in living amyloid precursor protein transgenic (Tg) mice. After the intravenous administration of N-[11 C]methyl-2-(4′-methylaminophenyl)-6-hydroxybenzothiazole (or [11 C]PIB for “Pittsburgh Compound-B”) with high-specific radioactivity, the Tg mice exhibited high-level retention of radioactivity in amyloid-rich regions. PET investigation for Tg mice over an extended range of ages, including longitudinal assessments, demonstrated age-dependent increase in radioligand binding consistent with progressive amyloid accumulation. Reduction in amyloid levels in the hippocampus of Tg mice was also successfully monitored by multiple PET scans along the time course of anti-amyloid treatment using an antibody against amyloid β peptide (Aβ). Moreover, PET scans with [18 F]fluoroethyl-DAA1106, a radiotracer for activated glia, were conducted for these individuals parallel to amyloid imaging, revealing treatment-induced neuroinflammatory responses, the magnitude of which intimately correlated with the levels of pre-existing amyloid estimated by [11 C]PIB. It is also noteworthy that the localization and abundance of [11 C]PIB autoradiographic signals were closely associated with those of N-terminally truncated and modified Aβ, AβN3-pyroglutamate, in Alzheimer's disease (AD) and Tg mouse brains, implying that the detectability of amyloid by [11 C]PIB positron emission tomography is dependent on the accumulation of specific Aβ subtypes. Our results support the usefulness of the small animal-dedicated PET system in conjunction with high-specific radioactivity probes and appropriate Tg models not only for clarifying the mechanistic properties of amyloidogenesis in mouse models but also for preclinical tests of emerging diagnostic and therapeutic approaches to AD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Vascular amyloid is somewhat different in composition and potentially conformation from parenchymal Aβ plaques.
“interestingly vascular amyloid is somewhat different in its composition 79 and potentially, its conformation from the parenchymal Aβ plaques 92 .”
From The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics (2022) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works
Self-citationDistribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G., Ding, Y., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,515 · see citing works
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · see citing works
Self-citationIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · see citing works
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
Orgogozo, J.-M., Gilman, S., Dartigues, J.-F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000073623.84147.a8 · Cited by 1,356 · see citing works
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · see citing works
Self-citation[ <sup>11</sup> C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · see citing works
Shoghi, K. I., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petrič, A., Huang, S., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 774 · see citing works
Treatment of Alzheimer's disease; current status and new perspectives
Scarpini, E. A., Scheltens, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 720 · see citing works
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., Holt, D. P., MELTZER, C. C., DeKosky, S. T., & Mathis, C. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600146 · Cited by 712 · see citing works
Ichise, M., Liow, J., Lu, J., Takano, A., Modell, K. J., Toyama, H., Suhara, T., Suzuki, K., Innis, R. B., & Carson, R. E. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000085441.37552.ca · Cited by 651 · see citing works
Self-citationTwo-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 614 · see citing works
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587 · see citing works
Self-citationComparison of Methods for Analysis of Clinical [ 11 C]Raclopride Studies
Lammertsma, A. A., Bench, C. J., Hume, S. P., Osman, S., Gunn, K. P., Brooks, D. J., & Frackowiak, R. S. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00005 · Cited by 460 · see citing works
(2005) · PubMed · Cited by 395 · see citing works
Klunk, W. E., Lopresti, B. J., Ikonomović, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., Debnath, M. L., Holt, D. P., Huang, G.-F., Shao, L., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2990-05.2005 · Cited by 376 · see citing works
Small Molecule Inhibitors of α-Synuclein Filament Assembly
Masuda, M., Suzuki, N., Taniguchi, S., Oikawa, T., Nonaka, T., Iwatsubo, T., Hisanaga, S., Goedert, M., & Hasegawa, M. (2006) · Biochemistry · doi:10.1021/bi0600749 · Cited by 367 · see citing works
In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe
Hintersteiner, M., Enz, A., Frey, P., Jaton, A.-L., Kinzy, W., Kneuer, R., Neumann, U., Rudin, M., Staufenbiel, M., Stoeckli, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1085 · Cited by 342 · see citing works
Self-citation19F and 1H MRI detection of amyloid β plaques in vivo
Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C. (2005) · Nature Neuroscience · doi:10.1038/nn1422 · Cited by 339 · see citing works
Self-citationIn-Vivo Imaging of Alzheimer Disease -Amyloid With [11C]SB-13 PET
Verhoeff, N. P. L. G. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.6.584 · Cited by 318 · see citing works
Styren, S. D., Hamilton, R. L., Styren, G. C., & Klunk, W. E. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800906 · Cited by 290 · see citing works
Bacskai, B. J., Hickey, G. A., Skoch, J. M., Kajdasz, S. T., Wang, Y., Huang, G.-F., Mathis, C. A., Klunk, W. E., & Hyman, B. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034101100 · Cited by 255 · see citing works
On the Seeding and Oligomerization of pGlu-Amyloid Peptides (<i>in vitro</i>)
Schilling, S., Lauber, T., Schaupp, M., Manhart, S., Scheel, E., Böhm, G., & Demuth, H.-U. (2006) · Biochemistry · doi:10.1021/bi0612667 · Cited by 254 · see citing works
Wilcock, D. M., DiCarlo, G., Henderson, D., Jackson, J., Clarke, K., Ugen, K. E., Gordon, M. N., & Morgan, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03745.2003 · Cited by 232 · see citing works
He, W., & Barrow, C. J. (1999) · Biochemistry · doi:10.1021/bi990563r · Cited by 216 · see citing works
Güntert, A., Döbeli, H., & Bohrmann, B. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.027 · Cited by 180 · see citing works
Zhang, M., Maeda, J., Ogawa, M., Noguchi, J., Ito, T., Yoshida, Y., Okauchi, T., Obayashi, S., Suhara, T., & Suzuki, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0304919 · Cited by 147 · see citing works
Self-citationToyama, H., Ye, D. G., Ichise, M., Liow, J., Cai, L., Jacobowitz, D. M., Musachio, J. L., Hong, J. S., Crescenzo, M., Tipre, D. N., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1780-5 · Cited by 126 · see citing works
Suzuki, K., Inoue, O., Hashimoto, K., Yamasaki, T., Kuchiki, M., & TAMATE, K. (1985) · The International Journal of Applied Radiation and Isotopes · doi:10.1016/0020-708x(85)90258-3 · Cited by 108 · see citing works
Self-citationPubertal Changes in Biochemical Markers of Growth
Federico, G., Baroncelli, G. I., Vanacore, T., Fiore, L., & Saggese, G. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071225 · Cited by 102 · see citing works
Immunotherapy for Alzheimer's disease
Dodel, R. C., Hampel, H. J., & Du, Y. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00349-1 · Cited by 102 · see citing works
Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques
Sato, K., Higuchi, M., Iwata, N., Saido, T. C., & Sasamoto, K. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.02.013 · Cited by 82 · see citing works
Self-citationAmyloid binding ligands as Alzheimer’s disease therapies
Lee, V. M. ‐. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00121-5 · Cited by 80 · see citing works
Shoghi-Jadid, K. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.1.24 · Cited by 65 · see citing works
X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease
Ikonomović, M. D., Abrahamson, E. E., Isanski, B. A., Debnath, M. L., Mathis, C. A., DeKosky, S. T., & Klunk, W. E. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12009-1 · Cited by 58 · see citing works
Noguchi, J., & Suzuki, K. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00422-5 · Cited by 58 · see citing works
Self-citationIn vivo amyloid imaging in Alzheimer?s disease
Sair, H. I., Doraiswamy, P. M., & Petrella, J. R. (2004) · Neuroradiology · doi:10.1007/s00234-003-1034-9 · Cited by 50 · see citing works
Mutant presenilin (A260V) affects Rab8 in PC12D cell
Kametani, F., Usami, M., Tanaka, K., Kume, H., & Mori, H. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00176-1 · Cited by 28 · see citing works
Self-citationImaging and In Vivo Quantitation of β-Amyloid: An Exemplary Biomarker for Alzheimer’s Disease?
Nichols, L. M., Pike, V. W., Cai, L., & Innis, R. B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.004 · Cited by 26 · see citing works
Zhang, M., & Suzuki, K. (2004) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.07.003 · Cited by 22 · see citing works
Self-citationPET imaging of transgenic mice TG2576 using the beta-amyloid radioligand, [C-11]PIB
Cai, L., Ye, D., Liow, J., Hong, J., Cohen, R. M., Pike, V. W., & Innis, R. B. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.04.125 · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750 · see citing works
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · see citing works
Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.037 · Cited by 760 · see citing works
Self-citationThe amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Karran, E., & De Strooper, B. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00391-w · Cited by 742 · see citing works
Metals in Alzheimer's and Parkinson's Diseases
Barnham, K. J., & Bush, A. I. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.019 · Cited by 695 · see citing works
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · see citing works
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel, H. J., Frank, R., Broich, K., Teipel, S. J., Katz, R. G., Hardy, J., Herholz, K., Bokde, A. L. W., Jessen, F., Hoessler, Y. C., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3115 · Cited by 630 · see citing works
Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis
Bush, A. I., & Tanzi, R. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.001 · Cited by 566 · see citing works
Inflammation, microglia, and alzheimer's disease
Cameron, B., & Landreth, G. E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.006 · Cited by 440 · see citing works
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
Chauveau, F., Boutin, H., Camp, N. V., Dollé, F., & Tavitian, B. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0908-9 · Cited by 419 · see citing works
Jucker, M. (2010) · Nature Medicine · doi:10.1038/nm.2224 · Cited by 401 · see citing works
Zhang, X., Tian, Y., Zeng, L., Tian, X., Sun, H., Liu, H. S., Moore, A. V., & Ran, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405239v · Cited by 359 · see citing works
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Fodero‐Tavoletti, M. T., Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G. J., et al. (2011) · Brain · doi:10.1093/brain/awr038 · Cited by 329 · see citing works
Villemagne, V. L., Pike, K. E., Darby, D., Maruff, P. T., Savage, G. R., Ng, S., Ackermann, U., Cowie, T., Currie, J. N., Chan, S. G., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.008 · Cited by 291 · see citing works
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 281 · see citing works
Potent amyloidogenicity and pathogenicity of Aβ43
Saito, T., Suemoto, T., Brouwers, N., Sleegers, K., Funamoto, S., Mihira, N., Matsuba, Y., Yamada, K., Nilsson, P., Takano, J., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2858 · Cited by 280 · see citing works
Self-citationThe role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266 · see citing works
Zhang, X., Tian, Y., Zhang, C. M., Tian, X., Ross, A., Moir, R. D., Sun, H., Tanzi, R. E., Moore, A. V., & Ran, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505420112 · Cited by 227 · see citing works
Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 226 · see citing works
Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease
Jawhar, S., Wirths, O., & Bayer, T. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.288308 · Cited by 220 · see citing works
Biomarkers of Alzheimer's disease
Craig‐Schapiro, R., Fagan, A. M., & Holtzman, D. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.003 · Cited by 217 · see citing works
Xuan, A., Long, D., Li, J., Ji, W., Zhang, M., Hong, L.-P., & Liu, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-202 · Cited by 211 · see citing works
Lee, Y., Choi, D., Yun, Y., Han, S., Oh, K., & Hong, J. T. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.011 · Cited by 195 · see citing works
Molecular imaging of microglia/macrophages in the brain
Venneti, S., Lopresti, B. J., & Wiley, C. A. (2012) · Glia · doi:10.1002/glia.22357 · Cited by 189 · see citing works
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
Zhang, L., Hu, K., Shao, T., Hou, L., Zhang, S., Ye, W., Josephson, L., Meyer, J. H., Zhang, M., Vasdev, N., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.006 · Cited by 187 · see citing works
Lee, Y. K., Yuk, D. Y., Lee, J. W., Lee, S. Y., Ha, T. Y., Oh, K. W., Yun, Y. P., & Hong, J. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.012 · Cited by 181 · see citing works
Kitazawa, M., Medeiros, R., & M. LaFerla, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315786 · Cited by 178 · see citing works
Schöll, M., Wall, A., Thordardottir, S., Ferreira, D., Bogdanovic, N., Långström, B., Almkvist, O., Graff, C., & Nordberg, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31825fdf18 · Cited by 169 · see citing works
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 176 · see citing works
Bouter, Y., Dietrich, K., Wittnam, J. L., Rezaei-Ghaleh, N., Pillot, T., Papot-Couturier, S., Lefebvre, T., Sprenger, F., Wirths, O., Zweckstetter, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1129-2 · Cited by 175 · see citing works
Wirths, O., Breyhan, H., Cynis, H., Schilling, S., Demuth, H.-U., & Bayer, T. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0557-5 · Cited by 174 · see citing works
Villemagne, V. L., Ataka, S., Mizuno, T., Brooks, W. S., Wada, Y., Kondo, M., Jones, G. R., Watanabe, Y., Mulligan, R. S., Nakagawa, M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.285 · Cited by 171 · see citing works
Self-citationImaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
Venneti, S., Wiley, C. A., & Kofler, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9142-2 · Cited by 168 · see citing works
Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169 · see citing works
Self-citationThe Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
Wong, D. F., Tauscher, J. T., & Gründer, G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.166 · Cited by 167 · see citing works
Bayer, T. A., & Wirths, O. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1287-x · Cited by 168 · see citing works
Sphingolipids: Critical players in Alzheimer’s disease
van Echten‐Deckert, G., & Walter, J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.07.001 · Cited by 172 · see citing works
Relevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A. I., Green, K. N., & LaFerla, F. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 147 · see citing works
Maeda, J., Zhang, M.-R., Okauchi, T., Ji, B., Ono, M., Hattori, S., Kumata, K., Iwata, N., Saido, T. C., Trojanowski, J. Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3076-10.2011 · Cited by 136 · see citing works
Self-citationMaier, F. C., Wehrl, H. F., Schmid, A. M., Mannheim, J. G., Wiehr, S., Lerdkrai, C., Calaminus, C., Stahlschmidt, A., Ye, L., Burnet, M. W. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3734 · Cited by 123 · see citing works
Self-citationBiomarkers in Alzheimer's disease drug development
Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 121 · see citing works
Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases
Endo, H., Ono, M., Takado, Y., Matsuoka, K., Takahashi, M., Tagai, K., Kataoka, Y., Hirata, K., Takahata, K., Seki, C., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.006 · Cited by 121 · see citing works
Self-citationMicrobial involvement in Alzheimer disease development and progression
Bulgart, H. R., Neczypor, E. W., Wold, L. E., & Mackos, A. R. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00378-4 · Cited by 116 · see citing works
Wang, A., Das, P., Switzer, R. C., Golde, T. E., & Jankowsky, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5077-10.2011 · Cited by 118 · see citing works
Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voß, A., Huisman, M. C., Settles, M., Neff, F., Velden, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031310 · Cited by 116 · see citing works
Koivunen, J., Verkkoniemi, A., Aalto, S., Paetau, A. E., Ahonen, J.-P., Viitanen, M. H., Någren, K., Rokka, J., Haaparanta‐Solin, M., Kalimo, H., et al. (2008) · Brain · doi:10.1093/brain/awn107 · Cited by 117 · see citing works
<i>In Vivo</i> mouse imaging and spectroscopy in drug discovery
Beckmann, N., Kneuer, R., Gremlich, H., Karmouty‐Quintana, H., Blé, F., & Müller, M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1153 · Cited by 118 · see citing works
In vivo molecular imaging of neuroinflammation in Alzheimer's disease
Chaney, A. M., Williams, S. R., & Boutin, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14615 · Cited by 116 · see citing works
Assessing the contribution of inflammation in models of Alzheimer's disease
Johnston, H. R., Boutin, H., & Allan, S. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390886 · Cited by 112 · see citing works
Morawski, M., Schilling, S., Kreuzberger, M., Waniek, A., Jäger, C., Koch, B. M., Cynis, H., Kehlen, A., Arendt, T., Hartlage‐Rübsamen, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131535 · Cited by 114 · see citing works
Doorduin, J., de Vries, E. F. J., Dierckx, R. A. J. O., & Klein, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549443 · Cited by 107 · see citing works
Harada, R., Okamura, N., Furumoto, S., Tago, T., Maruyama, M., Higuchi, M., Yoshikawa, T., Arai, H., Iwata, R., Kudo, Y., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2261-2 · Cited by 108 · see citing works
Self-citationGlobal brain delivery of neprilysin gene by intravascular administration of AAV vector in mice
Iwata, N., Sekiguchi, M., Hattori, Y., Takahashi, A., Asai, M., Ji, B., Higuchi, M., Staufenbiel, M., Muramatsu, S., & Saido, T. C. (2013) · Scientific Reports · doi:10.1038/srep01472 · Cited by 107 · see citing works
Self-citationPyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
Wirths, O., Bethge, T., Marcello, A., Harmeier, A., Jawhar, S., Lucassen, P. J., Multhaup, G., Brody, D. L., Esparza, T., Ingelsson, M., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0314-x · Cited by 106 · see citing works
Jawhar, S., Wirths, O., Schilling, S., Graubner, S., Demuth, H., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.185819 · Cited by 105 · see citing works
Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease
Shin, J., Lee, S., Kim, S., Kim, Y.-B., & Cho, S. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.022 · Cited by 101 · see citing works
Alexandru, A., Jagla, W., Graubner, S., Becker, A., Bäuscher, C., Kohlmann, S., Sedlmeier, R., Raber, K. A., Cynis, H., Rönicke, R., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1794-11.2011 · Cited by 102 · see citing works
Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology
Higuchi, M., Iwata, N., Matsuba, Y., Takano, J., Suemoto, T., Maeda, J., Ji, B., Ono, M., Staufenbiel, M., Suhara, T., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-187740 · Cited by 102 · see citing works
Self-citationThe Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design
Scarf, A. M., Ittner, L. M., & Kassiou, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8011678 · Cited by 98 · see citing works
Rosen, R. F., Walker, L. C., & LeVine, H. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.011 · Cited by 97 · see citing works
The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
Villemagne, V. L., Fodero‐Tavoletti, M. T., Pike, K. E., Cappai, R., Masters, C. L., & Rowe, C. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8019-y · Cited by 97 · see citing works
A review of β-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93 · see citing works
Kuntner, C., Kesner, A., Bauer, M., Kremslehner, R., Wanek, T., Mandler, M., Karch, R., Stanek, J., Wolf, T., Müller, M., et al. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0198-z · Cited by 90 · see citing works
The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation
Klunk, W. E., & Mathis, C. A. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283168e1a · Cited by 92 · see citing works
Rojas, S., Herance, J. R., Gispert, J. D., Abad, S., Llongarriu, È. T., Jiménez, X., Pareto, D., Perpiñá, U., Sarroca, S., Rodrı́guez, E., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.027 · Cited by 87 · see citing works
Amyloid plaque imaging in vivo: current achievement and future prospects
Nordberg, A. K. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0700-2 · Cited by 86 · see citing works
Ikonomovic, M., Abrahamson, E., Price, J., Hamilton, R., Mathis, C., Paljug, W. R., Debnath, M., Cohen, A., Mizukami, K., Dekosky, S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0943-2 · Cited by 90 · see citing works
Rominger, A., Brendel, M., Burgold, S., Keppler, K., Baumann, K., Xiong, G., Mille, E., Gildehaus, F., Carlsen, J., Schlichtiger, J., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114660 · Cited by 83 · see citing works
Quantitative preclinical PET imaging: opportunities and challenges
Kuntner, C., & Stout, D. (2014) · Frontiers in Physics · doi:10.3389/fphy.2014.00012 · Cited by 84 · see citing works
Svedberg, M. M., Hall, H., Hellström‐Lindahl, E., Estrada, S., Guan, Z.-Z., Nordberg, A. K., & Långström, B. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.016 · Cited by 83 · see citing works
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82 · see citing works
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer’s disease
Rosen, R. F., Ciliax, B. J., Wingo, T. S., Gearing, M., Dooyema, J. M., Lah, J. J., Ghiso, J. A., LeVine, H., & Walker, L. C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0583-3 · Cited by 82 · see citing works
Snellman, A., Lopez‐Picon, F. R., Rokka, J., Salmona, M., Forloni, G., Scheinin, M., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110163 · Cited by 82 · see citing works
Alternative pathways for production of β-amyloid peptides of Alzheimer's disease
HOOK, V. Y. H., Schechter, I., Demuth, H., & Hook, G. (2008) · Biological Chemistry · doi:10.1515/bc.2008.124 · Cited by 82 · see citing works
Toward more efficient clinical trials for amyotrophic lateral sclerosis
Cudkowicz, M., Katz, J., Moore, D. H., O’Neill, G. N., Glass, J. D., Mitsumoto, H., Appel, S. H., Ravina, B. M., Kieburtz, K. D., Shoulson, I., et al. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903358865 · Cited by 81 · see citing works
Amyloid-β Peptide and Oligomers in the Brain and Cerebrospinal Fluid of Aged Canines
Head, E., Pop, V., Sarsoza, F. M., Kayed, R., Beckett, T. L., Studzinski, C. M., Tomic, J. L., Glabe, C. G., & Murphy, M. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1397 · Cited by 80 · see citing works
Yu, I., Inaji, M., Maeda, J., Okauchi, T., Nariai, T., Ohno, K., Higuchi, M., & Suhara, T. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1196 · Cited by 80 · see citing works
Self-citationThe value of incomplete mouse models of Alzheimer’s disease
Radde, R., Duma, C. C., Goedert, M., & Jucker, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0704-y · Cited by 81 · see citing works
Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease
Gunn, A. P., Masters, C. L., & Cherny, R. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.015 · Cited by 79 · see citing works
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79 · see citing works
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition
Poisnel, G., Dhilly, M., Moustié, O., Delamare, J., Abbas, A., Guilloteau, D., & Barré, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.024 · Cited by 75 · see citing works
Wittnam, J. L., Portelius, E., Zetterberg, H., Gustavsson, M. K., Schilling, S., Koch, B. C. P., Demuth, H., Blennow, K., Wirths, O., & Bayer, T. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308601 · Cited by 77 · see citing works
Schilling, S., Appl, T., Hoffmann, T., Cynis, H., Schulz, K., Jagla, W., Friedrich, D., Wermann, M., Buchholz, M., Heiser, U. F., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05471.x · Cited by 76 · see citing works
Yousefi, B. H., Manook, A., Drzezga, A. E., von Reutern, B., Schwaiger, M., Wester, H., & Henriksen, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101129a · Cited by 72 · see citing works
Ono, M., Watanabe, R., Kawashima, H., Cheng, Y., Kimura, H., Watanabe, H., Haratake, M., Saji, H., & Nakayama, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901057p · Cited by 71 · see citing works
Self-citationIshikawa, A., Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170509 · Cited by 69 · see citing works
Self-citationOverhoff, F., Brendel, M., Jaworska, A. M., Korzhova, V., Delker, A., Probst, F., Focke, C., Gildehaus, F., Carlsen, J., Baumann, K., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00045 · Cited by 65 · see citing works
Developing new molecular imaging probes for PET
Serdons, K., Verbruggen, A., & Bormans, G. M. (2009) · Methods · doi:10.1016/j.ymeth.2009.03.010 · Cited by 66 · see citing works
Wang, X., Wang, C., Chan, H., Iyaswamy, A., Krishnamoorthi, S. K., Li, M., Li, H., & Wong, M. S. (2020) · Talanta · doi:10.1016/j.talanta.2020.121830 · Cited by 65 · see citing works
Chiquita, S., Ribeiro, M., Castelhano, J., Oliveira, F., Sereno, J., Batista, M., Abrunhosa, A., Rodrigues-Neves, A. C., Carecho, R., Baptista, F., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz045 · Cited by 63 · see citing works
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
Hartlage‐Rübsamen, M., Waniek, A., Meißner, J., Morawski, M., Schilling, S., Jäger, C., Kleinschmidt, M., Cynis, H., Kehlen, A., Arendt, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1395-2 · Cited by 61 · see citing works
Yui, J., Maeda, J., Kumata, K., Kawamura, K., Yanamoto, K., Hatori, A., Yamasaki, T., Nengaki, N., Higuchi, M., & Zhang, M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.072223 · Cited by 62 · see citing works
Self-citationAmyloid Imaging with PET in Early Alzheimer Disease Diagnosis
Rowe, C. C., & Villemagne, V. L. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.12.017 · Cited by 61 · see citing works
Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 60 · see citing works
Virdee, K., Cumming, P. D., Caprioli, D., Jupp, B., Rominger, A., Aigbirhio, F. I., Fryer, T. D., Riss, P. J., & Dalley, J. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.009 · Cited by 60 · see citing works
In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer
Fodero‐Tavoletti, M. T., Brockschnieder, D., Villemagne, V. L., Martin, L., Connor, A. R., Thiele, A., Berndt, M., McLean, C., Krause, S., Rowe, C. C., et al. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.03.001 · Cited by 59 · see citing works
In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging
Verdurand, M., Levigoureux, E., Zeinyeh, W., Berthier, L., Mendjel, M., Cadarossanesaib, F., Bouillot, C., Iecker, T., Terreux, R., Lancelot, S., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00229 · Cited by 60 · see citing works
Snellman, A., Rokka, J., Lopez‐Picon, F. R., Eskola, O., Wilson, I., Farrar, G., Scheinin, M., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2178-9 · Cited by 58 · see citing works
Integrating ADNI results into Alzheimer's disease drug development programs
Cummings, J. L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.016 · Cited by 58 · see citing works
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C., Brooks, D. J., Hyman, B. T., Ikonomović, M. D., Ishii, K., Jack, C. R., Jagust, W. J., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2045-0 · Cited by 58 · see citing works
- Authors
- Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., Suzuki, K., Mori, H., Higuchi, M., & Suhara, T.
- Affiliations
- National Institute of Radiological Sciences (JP)
- Osaka City University (JP)
- Novartis (Switzerland) (CH)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Higuchi, Makoto
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-10-10
- Volume
- 27
- Issue
- 41
- Pages
- 10957-10968
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6672864
- OpenAlex
- W1984320700
- Cited by
- 300
- References
- 45
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 2 · 2022: 8 · 2021: 10 · 2020: 18 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 15 · 2014: 21 · 2013: 23 · 2012: 38
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (18023033, 18023040)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid imaging, Pittsburgh compound B, [11C]PIB, amyloid precursor protein transgenic mice, neuroinflammation, amyloid-beta, amyloid accumulation, hippocampus, longitudinal imaging
- MeSH terms
- Age Factors, Alzheimer Disease, Aniline Compounds, Animals, Antibodies, Disease Models, Animal, Female, Inflammation, Longitudinal Studies, Mice, Inbred C57BL, Mice, Transgenic, Thiazoles, Amyloid beta-Peptides, Neurofibrillary Tangles, Positron-Emission Tomography, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
